Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Kathy Giusti to Address HBS Graduating Class
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
![Photograph courtesy of the Multiple Myeloma Research Foundation Kathy Giusti](/sites/default/files/styles/topic_teaser_mobile_d7/public/img/article/0511/screen_shot_2011-05-06_at_4.00.16_pm.png?itok=MZmLFP5A)
You might also like
The Cost of Political Violence
A Harvard discussion on increasing threats and how to stop them
Former Women’s Hockey Coach Sues Harvard
Katey Stone alleges gender bias in handling of abuse allegations that led to her retirement.
Remembering Helen Keller and Anne Sullivan
On a Radcliffe-Harvard memorial to remarkable figures
Most popular
More to explore
Broadway Director from Harvard Adapting Disney
Broadway music director Madeline Benson on art and collaboration
How Political Tension on Campus Creates Risk Aversion
How overheated political attention warps campus life
Harvard Professor on Social Psychology for Understanding War
Two scholars’ extracurricular efforts in the Middle East